n(6)-carboxymethyllysine has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albanes, D; Freedman, ND; Jiao, L; Moy, KA; Sinha, R; Stolzenberg-Solomon, RZ; Virtamo, J; Weinstein, SJ | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Liver Neoplasms
| Article | Year |
|---|---|
Soluble receptor for advanced glycation end products and risk of liver cancer.
Topics: Aged; Carcinoma, Hepatocellular; Finland; Glycation End Products, Advanced; Humans; Liver Neoplasms; Lysine; Male; Middle Aged; Randomized Controlled Trials as Topic; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors | 2013 |